Skip to content

GenePOC Strep A

by Genepoc, Inc.

510(k) K183366

GenePOC Strep A is a medical device (FDA Class II; FDA product code PGX, Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System) made by Genepoc, Inc., cleared under FDA 510(k) K183366 on 6 Mar 2019, active as of 11 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 11 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 11 Oct 2026.

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK183366 Date6 Mar 2019ClearedStatusActive

Official records

From the FDA record

Received by the FDA
4 Dec 2018
FDA decision
6 Mar 2019 (Substantially Equivalent)
FDA review time
92 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K183366 (openFDA), as read on 11 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
PGX
Device class
Class II
Regulation
21 CFR Part 866.2680
Advisory committee
Microbiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code PGX (Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System).

Other devices from Genepoc, Inc.

  • revogene™ 130840 Open recall

    Class II
  • GenePOC CDiff Open recall

    Class II
  • GenePOC Carba

    Class II
  • revogene Open recall

    Class II

See all devices from Genepoc, Inc. →